|
1. Wang, Y. Y., K. H. Khoo, S. T. Chen, C. C. Lin, C. H. Wong, and C. H. Lin. 2002. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein Responsible for the activities. Bioorg. Med. Chem. 10: 1057-1062. 2. Lin, Z. B. 2005. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J. Pharmacol. Sci. 99: 144-153. 3. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1: 135-145. 4. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nature Rev. Immunol. 4: 499-511. 5. Liu, H., M. Komai-Koma, D. Xu, and F. Y. Liew. 2006. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 7048-7053. 6. Hsu, H. Y., K. F. Hua, C. C. Lin, C. H. Lin, J. Hsu, and C. H. Wong. 2004. Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. J. Immunol. 173: 5989-5999. 7. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226. 8. Cong, Y., A. Konrad, N. Iqbal, R. D. Hatton, C. T. Weaver, and C. O. Elson. 2005. Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function. J. Immunol. 174: 2787-2795. 9. Shevach, E. M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400. 10. Sakaguchi, S. 2001. Policing the regulators. Nat. Immunol. 2: 283-284. 11. Levings, M. K., R. Sangregorio, and M. G. Roncarolo. 2001. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1301. 12. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nature Immunol. 4: 330-336. 13. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. 14. Read, S., V. Malmstrom, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302. 15. Testi R, Phillips JH, and Lanier LL. 1989. T cell activation via Leu-23 (CD69). J. Immunol. 143: 1123-1128. 16. Sancho D, Gómez M, and Sánchez-Madrid F. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends. Immunol. 26: 136-40. 17. Sakaguchi S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458. 18. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679. 19. Moore KW., R. de Waal Malefyt, RL. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683–765. 20. Scheffold, A., H. Jochen, and H. Thomas. 2005. Regulation of CD4+CD25+ regulatory T cell activity:it takes (IL-)two to tango. Eur. J. Immunol. 35: 1336-1341. 21. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming Growth Factor-β Regulation of Immune Responses. Annu. Rev. Immunol. 24: 99-146. 22. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16: 137-161. 23. Huber, S., C. Schramm, H. A. Lehr, A. Mann, S. Scbmitt, C. Becker, M. Protschka, P. R. Galle, M. F. Neurath, and M. Blessing. 2004. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J. Immunol. 173: 6526-6531. 24. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. 2003. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886. 25. Huang, T. J., P. A. MacAry, T. Wilke, D. M. Kemeny, and K. F. Chung. 1999. Inhibitory effects of endogenous and exogenous interferon-gamma on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats. Immunol. 98: 280-288. 26. Wang, Z., J. Hong, W. Sun, G. Xu, N. Li, X. Chen, A. Liu, L. Xu, B. Sun, and J. Z. Zhang. 2006. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J. Clin. Invest. 116: 2434-2441. 27. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J., S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87-99. 28. Skapenko, A., J. R. Kalden, P. E. Lipsky, and H. Schulze-Koops. 2005. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. Immunol. 175: 6107-6116. 29. Kim, Y. G., C. K. Lee, S. S. Nah, S. H. Mun, B. Yoo, and H. B. Moon. 2007. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 357: 1046-1052. 30. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T. W. Mak, and S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310. 31. Sancho, D., M. Gómez, and F. Sánchez-Madrid. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends. Immunol. 26: 136-140. 32. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate Immune recognition. Annu. Rev. Immunol. 20: 197-216. 33. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-Like Receptor. Annu. Rev. Immunol. 21: 335-376. 34. Pasare, C., and R. Medzhitov. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560: 11-18. 35. Gelman, A. E., J. Zhang, Y. Choi, and L. A. Turka1. 2004. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 172: 6065–6073. 36. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886. 37. Fu, S., N. Zhang, A. C. Yopp, D. Chen, M. Mao, D. Chen, H. Zhang, Y. Ding, and J. S. Bromberg. 2004. TGF- �ninduces Foxp3+ T-regulatory cells from CD4+CD25- precursors. Am. J. Transplant. 4: 1614-1627. 38. Zorn, E., E. A. Nelson, M. Mohseni, F. Porcheray, H. Kim, D. Litsa, R. Bellucci, E. Raderschall, C. Canning, R. J. Soiffer, D. A. Frank, and J. Ritz. 2006. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579. 39. Lin, K. I., Y. Y. Kao, H. K. Kuo, W. B. Yang, A. Chou, H. H. Lin, A. L. Yu, and C. H. Wong. 2006. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J. Biol. Chem. 281: 24111-24123. 40. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411. 41. Li, B., B. L. Arabinda, , S. X. Song, K. Furuuchi, K. T. Iacono, S. Kennedy, M. Katsumata, S. J. Saouaf, and M. I. Greene. 2006. FOXP3 ensembles in T-cell regulation. Immunol. Rev. 212: 99-113. 42. Paust, S., L. Lu, N. McCarty, and H. Cantor. 2004. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101: 10398-10403. 43. Bayer, A. L., A. Yu, D. Adeegbe, and T. R. Malek. 2005. Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. J. Exp. Med. 201: 769-777. 44. Schluns K. S., and L. Lefrançois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3: 269-279.
|